← Leaderboards
Don X Nguyen
Yale University
$10,390,286
Attributed
$12,324,672
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,324,672 · 7
By mechanism
R01$5,687,437 · 2
U01$3,868,773 · 1
P50$2,370,110 · 3
R21$398,352 · 1
Top collaborators
- Katerina Abigail Politi5 shared
Most similar at Yale University
Same institution · by research overlap
- Kathleen Ann Martin$14,895,788
- Anne Christine Eichmann$13,173,934
- Michael Cecchini$1,304,790
- Dieter G Soll$29,619,061
- Harriet M Kluger$18,066,555
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsBiologicalTumorNeoplasm MetastasisCellsCancer PatientMalignant Neoplasm Of LungSourceInsightMolecularMalignant Neoplasm Of ThoraxMutationTissuesRelapseBiologyCessation Of LifeProgramsLung AdenocarcinomaMalignant NeoplasmsGeneticLinkResponseIn VivoTumor Microenvironment
Grant awards (28)
Project 3: The ATM Kinase as a Therapeutic Target in Drug Resistant NSCLC with Brain Metastasis$418,152
P50 · FY2025 · CA · contact PI
Project 3: Identifying and targeting mediators of CNS metastasis from lung cancer$393,173
P50 · FY2024 · CA · contact PI
A NOVEL LINEAGE SPECIFIC METASTASIS PATHWAY IN LUNG CANCER$377,922
R01 · FY2024 · CA · contact PI
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.$728,983
U01 · FY2023 · CA
A NOVEL LINEAGE SPECIFIC METASTASIS PATHWAY IN LUNG CANCER$389,856
R01 · FY2023 · CA · contact PI
Project 3: Identifying and targeting mediators of CNS metastasis from lung cancer$380,886
P50 · FY2023 · CA · contact PI
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.$749,308
U01 · FY2022 · CA
A NOVEL LINEAGE SPECIFIC METASTASIS PATHWAY IN LUNG CANCER$389,856
R01 · FY2022 · CA · contact PI
Project 3: Identifying and targeting mediators of CNS metastasis from lung cancer$378,262
P50 · FY2022 · CA · contact PI
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.$778,382
U01 · FY2021 · CA
A NOVEL LINEAGE SPECIFIC METASTASIS PATHWAY IN LUNG CANCER$397,813
R01 · FY2021 · CA · contact PI
Project 3: Identifying and targeting mediators of CNS metastasis from lung cancer$390,080
P50 · FY2021 · CA · contact PI
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.$798,050
U01 · FY2020 · CA
Project 3: Identifying and targeting mediators of CNS metastasis from lung cancer$409,557
P50 · FY2020 · CA · contact PI
A NOVEL LINEAGE SPECIFIC METASTASIS PATHWAY IN LUNG CANCER$397,813
R01 · FY2020 · CA · contact PI
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.$814,050
U01 · FY2019 · CA
A novel lineage pathway controls metabolic adaptation by metastatic lung cancers$368,869
R01 · FY2019 · CA · contact PI
A novel lineage pathway controls metabolic adaptation by metastatic lung cancers$380,278
R01 · FY2018 · CA · contact PI
A novel lineage pathway controls metabolic adaptation by metastatic lung cancers$380,278
R01 · FY2017 · CA · contact PI
A novel lineage pathway controls metabolic adaptation by metastatic lung cancers$380,278
R01 · FY2016 · CA · contact PI
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer$355,819
R01 · FY2016 · CA · contact PI
A novel lineage pathway controls metabolic adaptation by metastatic lung cancers$380,278
R01 · FY2015 · CA · contact PI
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer$365,216
R01 · FY2015 · CA · contact PI
Epigenetic modulation of lung cancer metastasis by a novel long intergenic RNA$181,069
R21 · FY2015 · CA · contact PI
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer$374,383
R01 · FY2014 · CA · contact PI
Epigenetic modulation of lung cancer metastasis by a novel long intergenic RNA$217,283
R21 · FY2014 · CA · contact PI
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer$363,372
R01 · FY2013 · CA · contact PI
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer$385,406
R01 · FY2012 · CA · contact PI